CYTK (Cytokinetics) General and Admin. Expense: $226.9 Mil (TTM As of Mar. 2026)


CYTK Cytokinetics Inc CYTK
51 GF Score
Price $84.88
GF Value $250.73
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Cytokinetics General and Admin. Expense?

Cytokinetics CYTK -0.79% 51 General and Admin. Expense is $226.9 Mil as of Mar. 2026. GuruFocus rates CYTK with a GF Score™ of 51/100 and a GF Value™ of $250.73 (Possible Value Trap). The stock has 8 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Cytokinetics's General and Admin. Expense for the three months ended in Mar. 2026 was $0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $226.9 Mil.

Cytokinetics General and Admin. Expense Related Terms

Cytokinetics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Cytokinetics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytokinetics General and Admin. Expense Chart

Cytokinetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.80 177.98 173.61 215.31 284.27

Cytokinetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 65.72 69.46 91.72 0.00
CYTK
51GF Score
Cytokinetics Inc CYTK
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytokinetics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $226.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $226.9 Mil mean?
Cytokinetics (CYTK) has a General and Admin. Expense of $226.9 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Cytokinetics and its competitors.
Is Cytokinetics' General and Admin. Expense too high?
Cytokinetics' current General and Admin. Expense is $226.9 Mil. Overall, Cytokinetics has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cytokinetics' General and Admin. Expense compare to ARWR and TECH?
Cytokinetics' General and Admin. Expense of $226.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Cytokinetics and its competitors. Cytokinetics's current General and Admin. Expense is $226.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytokinetics stock overvalued right now?
Based on GuruFocus' analysis, Cytokinetics (CYTK) is currently considered Possible Value Trap. The stock's GF Value™ is $250.73, compared to a current price of $84.88 — trading 66.1% below its estimated fair value. The current General and Admin. Expense is $226.9 Mil. Cytokinetics' overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Cytokinetics (CYTK), the current General and Admin. Expense is $226.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cytokinetics (CYTK) Overvalued in 2026?

Based on GuruFocus' analysis, Cytokinetics stock appears to be undervalued. The current stock price of $84.88 is trading 66.1% below its estimated GF Value™ of $250.73. GuruFocus considers Cytokinetics to be Possible Value Trap.

Key valuation signals for CYTK:

  • General and Admin. Expense: $226.9 Mil
  • GF Value™: $250.73 vs. price of $84.88 (66.1% below fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the CYTK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cytokinetics Business Description

Other Exchanges 1CYTK:ItalyKK3A:Germany
Address 350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
51GF Score

Get the complete analysis for CYTK

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$84.88
Price
$250.73
GF Value